IEQ Capital’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-7,222
| Closed | -$77.4K | – | 1014 |
|
2023
Q4 | $77.4K | Hold |
7,222
| – | – | ﹤0.01% | 891 |
|
2023
Q3 | $43.3K | Hold |
7,222
| – | – | ﹤0.01% | 921 |
|
2023
Q2 | $49.8K | Hold |
7,222
| – | – | ﹤0.01% | 879 |
|
2023
Q1 | $113K | Hold |
7,222
| – | – | ﹤0.01% | 850 |
|
2022
Q4 | $144K | Hold |
7,222
| – | – | ﹤0.01% | 754 |
|
2022
Q3 | $129K | Hold |
7,222
| – | – | ﹤0.01% | 791 |
|
2022
Q2 | $160K | Hold |
7,222
| – | – | ﹤0.01% | 745 |
|
2022
Q1 | $201K | Buy |
7,222
+3,611
| +100% | +$101K | ﹤0.01% | 767 |
|
2021
Q4 | $164K | Hold |
3,611
| – | – | ﹤0.01% | 704 |
|
2021
Q3 | $301K | Hold |
3,611
| – | – | 0.01% | 555 |
|
2021
Q2 | $343K | Hold |
3,611
| – | – | 0.01% | 436 |
|
2021
Q1 | $601K | Hold |
3,611
| – | – | 0.02% | 259 |
|
2020
Q4 | $354K | Hold |
3,611
| – | – | 0.02% | 203 |
|
2020
Q3 | $123K | Hold |
3,611
| – | – | 0.01% | 378 |
|
2020
Q2 | $205K | Hold |
3,611
| – | – | 0.01% | 293 |
|
2020
Q1 | $212K | Buy |
+3,611
| New | +$212K | 0.02% | 331 |
|